Wealth Quarterback’s Novo Nordisk NVO Stock Holding History

Wealth Quarterback’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$665K	Buy	18,107 +2,298	+15%	+$109K	0.26%	70
2025 Q4	$804K	Sell	15,809 -4,605	-23%	-$235K	0.29%	61
2025 Q3	$1.13M	Buy	20,414 +598	+3%	+$35K	0.44%	46
2025 Q2	$1.37M	Buy	19,816 +3,795	+24%	+$258K	0.65%	36
2025 Q1	$1.11M	Buy	16,021 +3,660	+30%	+$302K	0.63%	35
2024 Q4	$1.06M	Buy	12,361 +5,174	+72%	+$560K	0.5%	42
2024 Q3	$856K	Buy	+7,187	New	+$958K	0.45%	50
2021 Q3	$45K	Buy	924 +264	+40%	+$12.8K	0.03%	254
2021 Q2	$28K	Buy	+660	New	+$25.6K	0.02%	304
2020 Q2	–	Sell	-644	Closed	-$19.4K	–	543
2020 Q1	$19.4K	Sell	644 -100	-13%	-$2.98K	0.02%	342
2019 Q4	$21.5K	Buy	+744	New	+$20.6K	0.02%	339

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Wealth Quarterback's NVO Position: Q1 2026 in Review

Wealth Quarterback increased its Novo Nordisk (NVO) stake by 15% in Q1 2026, buying an estimated $109K and bringing the position to 18,107 shares worth $665K. The position accounts for 0.26% of the portfolio, ranked #70.

Wealth Quarterback first reported a position in NVO in Q4 2019 and has held it in 11 quarters since. The position peaked at $1.37M in Q2 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Wealth Quarterback held 18,107 shares of Novo Nordisk worth $665K as of Q1 2026.
Wealth Quarterback bought 2,298 Novo Nordisk shares in Q1 2026, an estimated $109K.
Novo Nordisk made up 0.26% of Wealth Quarterback's portfolio in Q1 2026, its #70 holding.
Wealth Quarterback first reported a position in Novo Nordisk in Q4 2019 and has held it in 11 quarters since.
Wealth Quarterback's Novo Nordisk position peaked at $1.37M in Q2 2025.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Wealth Quarterback's 13F filing for Q1 2026, filed 9 Apr 2026.